Patrick Heron

Patrick Heron

Directeur/Bestuurslid bij ARCUTIS BIOTHERAPEUTICS, INC.

Vermogen: 2 M $ op 31-05-2026

55 jaar
Health Technology
Commercial Services
Finance

Profiel

Mr. Patrick J.
Heron
is a Lead Independent Director at MBX Biosciences, Inc., an Independent Director at Mirum Pharmaceuticals, Inc., an Independent Director at Arcutis Biotherapeutics, Inc. and a Managing Partner at Frazier Management LLC.
He is on the Board of Directors at MBX Biosciences, Inc., Mirum Pharmaceuticals, Inc., Arcutis Biotherapeutics, Inc., Alpha-9 Oncology, Inc., Bluewater Biosciences, Inc., Iterum Therapeutics International Ltd., Iterum Therapeutics US Holding Ltd., VentiRx Pharmaceuticals, Inc., Zavante Therapeutics, Inc. and Calibrium LLC.
Mr. Heron was previously employed as an Independent Director by HilleVax, Inc., an Independent Non-Executive Director by Passage Bio, Inc., a Chairman by Scout Bio, Inc., an Independent Director by Vaxcyte, Inc., an Independent Director by Iterum Therapeutics Plc, an Independent Director by Tobira Therapeutics, Inc., an Independent Director by Imago BioSciences, Inc., an Independent Director by Cidara Therapeutics, Inc., an Independent Director by Collegium Pharmaceutical, Inc., an Independent Director by Tobira Therapeutics, Inc. /Old/, an Engagement Manager by McKinsey & Co., Inc., a Principal by Cetus Corp., a Chairman by Kalidex Pharmaceuticals, Inc., and a Principal by The General Hospital Corp.
He also served on the board at SanReno Therapeutics, Silvergate Pharmaceuticals, Inc., Calixa Therapeutics, Inc., Marcadia Biotech, Inc., Cerexa, Inc., Trubion Pharmaceuticals, Inc., MedPointe, Inc., QuatRx Pharmaceuticals Co., Amunix, Inc., ARMO Biosciences, Inc., Avera Pharmaceuticals, Inc., Chimerix, Inc., Ignyta, Inc., Informed Medical Communications, Inc., Moximed, Inc., Panomics LLC, PreCision Dermatology, Inc. and Recida Therapeutics, Inc. He received his undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from Harvard Business School.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
05-06-2026 32.213 ( 0,03% ) 691 291 $ 31-05-2026
15-06-2026 5.703 ( 0,01% ) 578 855 $ 31-05-2026
0,03%
31-01-2025 9.110 ( 0,03% ) 507 154 $ 31-05-2026
0,02%
01-11-2025 14.937 ( 0,02% ) 143 246 $ 31-05-2026
04-06-2026 0 ( -.--% ) - $ 31-05-2026

Actieve functies van Patrick Heron

BedrijvenFunctieBegin
ARCUTIS BIOTHERAPEUTICS, INC. Directeur/Bestuurslid -
MIRUM PHARMACEUTICALS, INC. Directeur/Bestuurslid 07-11-2018
MBX BIOSCIENCES, INC. Directeur/Bestuurslid 01-07-2020
Private Equity Investor 01-08-1999
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -

Eerdere bekende functies van Patrick Heron

BedrijvenFunctieEinde
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Patrick Heron in detail bekijken

Opleiding van Patrick Heron

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

76

Eerstegraads connecties

45

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit45

Finance

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Beurs
  2. Insiders
  3. Patrick Heron
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU